Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients

NuklearMedizin

Volumn 50, Issue 1, 2011, Pages 3-8

  Mohagheghie, A ^a   Ahmadabadi, M N ^a   Hedayat, D K ^a   Pourbehi, M R ^b   Assadi, Majid ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asymptomatic diabetic patients; Coronary artery disease; Haemoglobin A1c; Myocardial perfusion imaging; Silent ischaemia

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIABETIC PATIENT; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 79952081170     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0318-10-05     Document Type: Article

References (37)

1. Adamu U, Knollmann D, Almutairi B et al. Stress/rest myocardial perfusion scintigraphy in patients without significant coronary artery disease. J Nucl Cardiol 2010; 17: 38-44.
2. Alqaisi F, Albadarin F, Jaffery Z et al. Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease. J Nucl Cardiol 2008; 15: 754-761.
3. 99mTc sestamibi SPECT studies without significant coronary artery diameter stenoses. Clin Cardiol 2003; 26: 521-524.
4. Assadi M, Nabipour I, Saghari M et al. The role of myocardial perfusion imaging in the screening of silent ischemia in diabetic patients. Iranian South Medical Journal 2010; 13: 59-71.
5. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998; 21: 1551-1559.
6. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-240.
7. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90: 827-832.
8. Delcour KS, Khaja A, Chockalingam A et al. Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiogram. Angiology 2009; 60: 318-321.
9. Di Carli MF, Bianco-Batlles D, Landa ME et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999; 100: 813-819. (Pubitemid 29398878)
10. Fard-Esfahani A, Assadi M, Saghari M et al. The role of myocardial perfusion imaging in the evaluation of patients undergoing percutaneous transluminal coronary angioplasty. Hellenic J Cardiol 2009; 50: 396-401.
11. Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med 1997; 14 (Suppl 3): S25-31.
12. Gibbons RJ, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2003; 107: 149-158.
13. Gimelli A, Marzullo P, L'Abbate A, Rovai D. 'Falsepositive' myocardial perfusion imaging: correlation with cardiovascular risk factors and effect on eventfree survival. J Cardiovasc Med (Hagerstown) 2008; 9: 707-713.
14. Giri S, Shaw LJ, Murthy DR et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105: 32-40. (Pubitemid 34049139)
15. Hasdai D, Gibbons RJ, Holmes DR Jr et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 3390-3395. (Pubitemid 27513410)
16. Iskandrian AE. The Achilles heel of SPECT imaging: the false-positive scans - or are they? J Nucl Cardiol 2006; 13: 747-748.
17. Janand-Delenne B, Savin B, Habib G et al. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396-1400. (Pubitemid 29418229)
18. Kang X, Berman DS, Lewin H et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999; 137: 949-957. (Pubitemid 29226307)
19. Kang X, Berman DS, Lewin HC et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138: 1025-1032.
20. Khaw KT, Wareham N, Bingham S et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
21. Kjaer A, Meyer C, Nielsen FS et al. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med 2003; 44: 19-23. (Pubitemid 36077707)
22. Liu YH, Sinusas AJ, DeMan P et al. Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CQ method. J Nucl Cardiol 1999; 6: 190-204.
23. Marshall SM, Barth JH. Standardization of HbA1c measurements - a consensus statement. Diabet Med 2000; 17: 5-6.
24. Miller TD, Rajagopalan N, Hodge DO et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 2004; 147: 890-896. (Pubitemid 38881004)
25. National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand. N Z Med J 1996; 109: 224-231.
26. Nishioka T, Amanullah AM, Luo H et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999; 33: 1870-1878.
27. Noble GL, Heller GV. Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes. Curr Cardiol Rep 2005; 7: 117-123. (Pubitemid 41630784)
28. Park S, Barrett-Connor E, Wingard DL et al. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 1996; 19: 450-456.
29. Passa P, Drouin P, Issa-Sayegh M et al. Coronary disease and diabetes. Diabets Metab 1995; 21: 446-451.
30. Pop-Busui R, Kirkwood I, Schmid H et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44: 2368-2374. (Pubitemid 39647612)
31. Rajagopalan N, Miller TD, Hodge DO et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress singlephoton emission computed tomography imaging. J Am Coll Cardiol 2005; 45: 43-49. (Pubitemid 40063548)
32. Rasulova N, Singh A, Demetriadou O et al. Clinical significance of myocardial perfusion abnormalities in patients with varying degree of coronary artery stenosis. Nucl Med Commun 2008; 29: 129-136. (Pubitemid 350306770)
33. Soman P, Dave DM, Udelson JE et al. Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol 2006; 13: 756-760. (Pubitemid 44890810)
34. Storto G, Sorrentino AR, Pellegrino T et al. Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. Eur J Nucl Med Mol Imaging 2007; 34: 1156-1161. (Pubitemid 47290657)
35. Wackers FJ, Chyun DA, Young LH et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 2007; 30: 2892-2898. (Pubitemid 350083141)
36. Wackers FJ, Young LH, Inzucchi SE et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27: 1954-1961. (Pubitemid 38989238)
37. Zellweger MJ, Hachamovitch R, Kang X et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004; 25: 543-550. (Pubitemid 38478546)